Total Payments
$52,983
2024 Payments
$569.32
Companies
45
Transactions
389
Payment Breakdown by Category
Other$19,021 (35.9%)
Food & Beverage$12,380 (23.4%)
Consulting$10,950 (20.7%)
Travel$7,734 (14.6%)
Research$2,779 (5.2%)
Education$118.36 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,580 | 7 | 23.7% |
| Food and Beverage | $12,380 | 328 | 23.4% |
| Consulting Fee | $10,950 | 3 | 20.7% |
| Travel and Lodging | $7,734 | 26 | 14.6% |
| Honoraria | $6,441 | 3 | 12.2% |
| Unspecified | $2,779 | 9 | 5.2% |
| Education | $118.36 | 13 | 0.2% |
Payments by Type
General
$50,204
380 transactions
Research
$2,779
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $19,498 | 36 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $7,191 | 21 | $0 (2021) |
| Amarin Pharma Inc. | $6,942 | 36 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $6,074 | 11 | $0 (2019) |
| Amgen Inc. | $2,285 | 35 | $0 (2024) |
| Genentech USA, Inc. | $1,531 | 6 | $0 (2023) |
| Eli Lilly and Company | $1,451 | 2 | $0 (2022) |
| Novo Nordisk AS | $1,329 | 7 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $882.24 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $809.27 | 39 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $569.32 | 7 | Janssen Pharmaceuticals, Inc ($135.59) |
| 2023 | $4,081 | 28 | Genentech USA, Inc. ($1,531) |
| 2022 | $955.24 | 12 | Esperion Therapeutics, Inc. ($310.71) |
| 2021 | $397.03 | 6 | Esperion Therapeutics, Inc. ($248.42) |
| 2020 | $6,169 | 18 | Amarin Pharma Inc. ($4,697) |
| 2019 | $3,297 | 69 | Amarin Pharma Inc. ($1,823) |
| 2018 | $25,626 | 136 | Kowa Pharmaceuticals America, Inc. ($10,645) |
| 2017 | $11,888 | 113 | Kowa Pharmaceuticals America, Inc. ($8,647) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $65.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $51.28 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $64.96 | General |
| Category: Neuroscience | ||||||
| 08/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $85.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.77 | General |
| 04/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $135.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $63.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $746.10 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $261.57 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $124.43 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $49.99 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $49.99 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $49.99 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/12/2023 | Novo Nordisk AS | Ozempic (Drug) | — | In-kind items and services | $46.63 | Research |
| Study: NN SELECT Results Meeting Philadelphia • Category: Diabetes | ||||||
| 11/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $133.64 | General |
| Category: Cardio-renal | ||||||
| 11/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $85.43 | General |
| Category: Cardiology | ||||||
| 11/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $76.75 | General |
| Category: Cardio-renal | ||||||
| 09/09/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Cardiology | ||||||
| 09/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $91.91 | General |
| Category: Cardiology | ||||||
| 08/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $82.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/22/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.27 | General |
| Category: Cardiology | ||||||
| 07/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $43.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $131.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/02/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN | Eli Lilly and Company | $1,451 | 2 |
| NN SELECT Results Meeting Philadelphia | Novo Nordisk AS | $1,329 | 7 |
About Dr. Neil Sheth, MD
Dr. Neil Sheth, MD is a Family Medicine healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982802930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neil Sheth, MD has received a total of $52,983 in payments from pharmaceutical and medical device companies, with $569.32 received in 2024. These payments were reported across 389 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,580).
Ad
Practice Information
- Specialty Family Medicine
- Location Chandler, AZ
- Active Since 07/10/2007
- Last Updated 11/06/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982802930
Products in Payments
- Livalo (Drug) $13,057
- PRALUENT ALIROCUMAB INJECTION (Biological) $7,498
- Vascepa (Drug) $6,942
- PRALUENT (Drug) $5,902
- Repatha (Biological) $1,606
- Ozempic (Drug) $1,448
- NEXLETOL (Drug) $691.36
- FARXIGA (Drug) $513.66
- LEQVIO (Drug) $513.62
- PRALUENT (Biological) $429.99
- XARELTO (Drug) $303.26
- TRULICITY (Drug) $239.54
- JANUVIA (Drug) $229.43
- Kerendia (Drug) $210.39
- Aimovig (Biological) $182.24
- HYPERLIPIDEMIA - DISEASE (Drug) $172.78
- IN.PACT Admiral (Device) $160.03
- LifeVest (Device) $145.52
- EVKEEZA (Biological) $145.04
- Optis Coronary Imaging System (Device) $136.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chandler
Jessica Blanco, Md, MD
Family Medicine — Payments: $371,097
Family Medicine $371,097
Dr. Richard Le, D.o, D.O
Family Medicine — Payments: $26,429
Family Medicine $26,429
Mr. Ronald Sell, Md, MD
Family Medicine — Payments: $22,702
Family Medicine $22,702
Dr. Cynthia Jordan, M.d, M.D
Family Medicine — Payments: $16,693
Family Medicine $16,693
Larry Tamburro, Md, MD
Family Medicine — Payments: $12,007
Family Medicine $12,007
Mr. David Gannon, Md, MD
Family Medicine — Payments: $11,717
Family Medicine $11,717